Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils

PLoS Computational Biology

Volumn 3, Issue 9, 2007, Pages 1727-1738

  Cheon, Mookyung ^a,b   Chang, Iksoo ^b   Mohanty, Sandipan ^c   Luheshi, Leila M ^a   Dobson, Christopher M ^a   Vendruscolo, Michele ^a   Favrin, Giorgio ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Pusan National University   (South Korea)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEINS; HYDROGEN BONDS; HYDROPHOBICITY; SURFACE CHEMISTRY;

ALZHEIMERS DISEASE; AMYLOID FIBRIL; HYDROPHOBICS; MOLECULAR SPECIES; NEUROLOGICAL DISORDERS; OLIGOMERIC PROTEINS; OLIGOMERIZATIONS; PARKINSON'S DISEASE; PROTEIN ASSEMBLY; STRUCTURAL REORGANIZATION;

OLIGOMERS;

AMYLOID; OLIGOMER; POLYPEPTIDE; SOLVENT;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; COMPUTER SIMULATION; CYTOTOXICITY; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN STRUCTURE;

EID: 34848929022     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0030173     Document Type: Article

References (64)

1. Selkoe DJ (2003) Folding proteins in fatal ways. Nature 426: 900-904. doi:10.1038/nature02264. Available: http://dx.doi.org/10.1038/nature02264. Accessed 8 August 2007.
2. Roberson ED, Mucke L (2006) 100 years and counting: Prospects for defeating Alzheimer disease. Science 314: 781-784. doi:10.1126/science.1132813. http://dx.doi.org/10.1126/science.1132813. Accessed 8 August 2007.
3. Lansbury PT, Lashuel HA (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443: 774-779. doi:10.1038/nature05290. Available: http://dx.doi.org/10.1038/nature05290. Accessed 8 August 2007.
4. Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24: 329-332.
5. Dobson CM (2003) Protein folding and misfolding. Nature 426: 884-890. doi:10.1038/nature02261. Available: http://dx.doi.org/10.1038/nature02261. Accessed 8 August 2007.
6. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366. doi:10.1146/annurev.biochem.75. 101304.123901. Available: http://dx.doi.org/10.1146/annurev.biochem.75.101304. 123901. Accessed 8 August 2007.
7. Harper JD, Wong SS, Lieber CM, Lansbury PT (1997) Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol 4: 119-125.
8. Harper JD, Lieber CM, Lansbury PT (1997) Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem Biol 4: 951-959.
9. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB (1997) Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem 272: 22364-22372.
10. Calamai M, Canale C, Relini A, Stefani M, Chiti F, et al. (2005) Reversal of protein aggregation provides evidence for multiple aggregated states. J Mol Biol 346: 603-616. doi:10.1016/j.jmb.2004.11.067. Available: http://dx.doi.org/10.1016/j.jmb.2004.11.067. Accessed 8 August 2007.
11. Bader R, Bamford R, Zurdo J, Luisi BF, Dobson CM (2006) Probing the mechanism of amyloidogenesis through a tandem repeat of the pi3-sh3 domain suggests a generic model for protein aggregation and fibril formation. J Mol Biol 356: 189-208. doi:10.1016/j.jmb.2005.11.034. Available: http://dx.doi.org/10.1016/j.jmb.2005.11.034. Accessed 8 August 2007.
12. Bitan G, Lomakin A, Teplow DB (2001) Amyloid beta-protein oligomerization: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem 276: 35176-35184. doi:10.1074/jbc.M102223200. Available: http://dx.doi.org/10.1074/jbc.M102223200. Accessed 8 August 2007.
13. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, et al. (2003) Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A 100: 330-335. doi:10.1073/pnas.222681699. http://dx.doi.org/10.1073/pnas.222681699. Accessed 8 August 2007.
14. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, et al. (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289: 1317-1321.
15. Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, et al. (1996) Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem 271: 20631-20635.
16. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, et al. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155: 853-862.
17. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539. doi:10.1038/416535a. Available: http://dx.doi.org/10.1038/416535a. Accessed 8 August 2007.
18. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ (2002) Amyloid-beta oligomers: Their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30: 552-557.
19. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, et al. (2003) Alzheimer's disease-affected brain: Presence of oligomeric a beta ligands (addls) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 100: 10417-10422. doi:10.1073/pnas.1834302100. Available: http://dx.doi.org/10.1073/pnas.1834302100. Accessed 8 August 2007.
20. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, et al. (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8: 79-84. doi:10.1038/nn1372. Available: http://dx.doi.org/10.1038/nn1372. Accessed 8 August 2007.
21. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112. doi:10.1038/nrm2101. Available: http://dx.doi.org/10.1038/nrm2101. Accessed 8 August 2007.
22. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511. doi:10.1038/416507a. Available: http://dx.doi.org/10.1038/416507a. Accessed 8 August 2007.
23. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489. doi:10.1126/science.1079469. Available: http://dx.doi.org/10.1126/science.1079469. Accessed 8 August 2007.
24. Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, et al. (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 279: 31374-31382. doi:10.1074/jbc.M400348200. Available: http://dx.doi.org/10.1074/jbc.M400348200. Accessed 8 August 2007.
25. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, et al. (2005) &fjThe most infectious prion protein particles. Nature 437: 257-261. doi:10.1038/nature03989. Available: http://dx.doi.org/10.1038/nature03989. Accessed 8 August 2007.
26. Baglioni S, Casamenti F, Bucciantini M, Luheshi LM, Taddei N, et al. (2006) Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci 26: 8160-8167. doi:10.1523/JNEUROSCI.4809-05.2006. Available: http://dx.doi.org/10.1523/JNEUROSCI.4809-05.2006. Accessed 8 August 2007.
27. Oh D, Shin SY, Lee S, Kang JH, Kim SD, et al. (2000) Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin a(1-8)-magainin 2(1-12), and its analogues, on their antibiotic activities and structures. Biochemistry 39: 11855-11864.
28. Oma Y, Kino Y, Sasagawa N, Ishiura S (2005) Comparative analysis of the cytotoxicity of homopolymeric amino acids. Biochim Biophys Acta 1748: 174-179. doi:10.1016/j.bbapap.2004.12.017. Available: http://dx.doi.org/10.1016/j.bbapap. 2004.12.017. Accessed 8 August 2007.
29. Ferre R, Badosa E, Feliu L, Planas M, Montesinos E, et al. (2006) Inhibition of plant-pathogenic bacteria by short synthetic cecropin a-melittin hybrid peptides. Appl Environ Microbiol 72: 3302-3308. doi:10.1128/AEM.72.5. 3302-3308.2006. http://dx.doi.org/10.1128/AEM.72.5.3302-3308.2006. Accessed 13 August 2007.
30. Plakoutsi G, Bemporad F, Calamai M, Taddei N, Dobson CM, et al. (2005) Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol 351: 910-922. doi:10.1016/j.jmb.2005.06.043. Available: http://dx.doi.org/10.1016/j.jmb.2005. 06.043. Accessed 8 August 2007.
31. Petty SA, Decatur SM (2005) Experimental evidence for the reorganization of beta-strands within aggregates of the Abeta(16-22) peptide. J Am Chem Soc 127: 13488-13489. doi:10.1021/ja054663y. Available: http://dx.doi.org/10.1021/ ja054663y. Accessed 8 August 2007.
32. Cerdà-Costa N, Esteras-Chopo A, Avilés FX, Serrano L, Villegas V (2007) Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. J Mol Biol 366: 1351-1363. doi:10.1016/j.jmb.2006.12.007. http://dx.doi.org/10.1016/j.jmb.2006.12.007. Accessed 8 August 2007.
33. Pellarin R, Caflisch A (2006) Interpreting the aggregation kinetics of amyloid peptides. J Mol Biol 360: 882-892. doi:10.1016/j.jmb.2006.05.033. Available: http://dx.doi.org/10.1016/j.jmb.2006.05.033. Accessed 8 August 2007.
34. Klimov DK, Thirumalai D (2003) Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets. Structure 11: 295-307.
35. Nguyen PH, Li MS, Stock G, Straub JE, Thirumalai D (2007) Monomer adds to preformed structured oligomers of Abeta-peptides by a two-stage dock-lock mechanism. Proc Natl Acad Sci U S A 104: 111-116. doi:10.1073/pnas.0607440104. Available: http://dx.doi.org/10.1073/pnas.0607440104. Accessed 8 August 2007.
36. Esler WP, Stimson ER, Jennings JM, Vinters HV, Ghilardi JR, et al. (2000) Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39: 6288-6295.
37. Thirumalai D, Klimov DK, Dima RI (2003) Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol 13: 146-159.
38. Nguyen HD, Hall CK (2004) Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci U S A 101: 16180-16185. doi:10.1073/pnas.0407273101. Available: http://dx.doi.org/10.1073/ pnas.0407273101. Accessed 8 August 2007.
39. Hwang W, Zhang S, Kamm RD, Karplus M (2004) Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc Natl Acad Sci U S A 101: 12916-12921. doi:10.1073/pnas.0402634101. Available: http://dx.doi.org/10.1073/ pnas.0402634101. Accessed 8 August 2007.
40. Buchete NV, Tycko R, Hummer G (2005) Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments. J Mol Biol 353: 804-821. doi:10.1016/j.jmb.2005.08.066. Available: http://dx.doi.org/10.1016/j.jmb.2005. 08.066. Accessed 8 August 2007.
41. de la Paz ML, de Mori GMS, Serrano L, Colombo G (2005) Sequence dependence of amyloid fibril formation: Insights from molecular dynamics simulations. J Mol Biol 349: 583-596. doi:10.1016/j.jmb.2005.03.081. http://dx.doi.org/10.1016/j.jmb.2005.03.081. Accessed 13 August 2007.
42. Khare SD, Ding F, Gwanmesia KN, Dokholyan NV (2005) Molecular origin of polyglutamine aggregation in neurodegenerative diseases. PLoS Comput Biol 1: 230-235. doi:10.1371/journal.pcbi.0010030. http://dx.doi.org/10.1371/journal. pcbi.0010030. Accessed 13 August 2007.
43. Hoang TX, Marsella L, Trovato A, Seno F, Banavar JR, et al. (2006) Common attributes of native-state structures of proteins, disordered proteins, and amyloid. Proc Natl Acad Sci U S A 103: 6883-6888. doi:10.1073/pnas.0601824103. Available: http://dx.doi.org/10.1073/pnas.0601824103. Accessed 8 August 2007.
44. Ma B, Nussinov R (2006) Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. Curr Opin Chem Biol 10: 445-452. doi:10.1016/j.cbpa.2006.08.018. Available: http://dx.doi.org/10.1016/j. cbpa.2006.08.018. Accessed 8 August 2007.
45. Teplow DB, Lazo ND, Bitan G, Bernstein S, Wyttenbach T, et al. (2006) Elucidating amyloid beta-protein folding and assembly: A multidisciplinary approach. Acc Chem Res 39: 635-645. doi:10.1021/ar050063s. Available: http://dx.doi.org/10.1021/ar050063s. Accessed 8 August 2007.
46. Boucher G, Mousseau N, Derreumaux P (2006) Aggregating the amyloid Abeta(11-25) peptide into a four-stranded beta-sheet structure. Proteins 65: 877-888. doi:10.1002/prot.21134. http://dx.doi.org/10.1002/prot.21134. Accessed 13 August 2007.
47. Santini S, Mousseau N, Derreumaux P (2004) In silico assembly of Alzheimer's Abeta16-22 peptide into beta-sheets. J Am Chem Soc 126: 11509-11516. doi:10.1021/ja047286i. Available: http://dx.doi.org/10.1021/ja047286i. Accessed 8 August 2007.
48. Urbanc B, Cruz L, Ding F, Sammond D, Khare S, et al. (2004) Molecular dynamics simulation of amyloid beta dimer formation. Biophys J 87: 2310-2321. doi:10.1529/biophysj.104.040980. Available: http://dx.doi.org/10.1529/biophysj. 104.040980. Accessed 8 August 2007.
49. Irbäck A, Samuelsson B, Sjunnesson F, Wallin S (2003) Thermodynamics of alpha- and beta-structure formation in proteins. Biophys J 85: 1466-1473.
50. Favrin G, Irbäck A, Mohanty S (2004) Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces. Biophys J 87: 3657-3664. doi:10.1529/biophysj.104.046839. Available: http://dx.doi.org/10. 1529/biophysj.104.046839. Accessed 8 August 2007.
51. Irbäck A, Sjunnesson F (2004) Folding thermodynamics of three beta-sheet peptides: A model study. Proteins 56: 110-116. doi:10.1002/prot. 20157. Available: http://dx.doi.org/10.1002/prot.20157. Accessed 8 August 2007.
52. Irbäck A, Mohanty S (2005) Folding thermodynamics of peptides. Biophys J 88: 1560-1569. doi:10.1529/biophysj.104.050427. http://dx.doi.org/10. 1529/biophysj.104.050427. Accessed 13 August 2007.
53. Irbäck A, Mohanty S (2006) Profasi: A monte carlo simulation package for protein folding and aggregation. J Comput Chem 27: 1548-1555. doi:10.1002/jcc.20452. Available: http://dx.doi.org/10.1002/jcc.20452. Accessed 8 August 2007.
54. Liao MQ, Tzeng YJ, Chang LYX, Huang HB, Lin TH, et al. (2007) The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett 581: 1161-1165. doi:10.1016/j.febslet.2007.02.026.
55. Lashuel HA, Lansbury PT (2006) Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys 39: 167-201. doi:10.1017/S0033583506004422. Available: http://dx.doi.org/10.1017/ S0033583506004422. Accessed 8 August 2007.
56. Milojevic J, Esposito V, Das R, Melacini G (2007) Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation nmr spectroscopy. J Am Chem Soc 10.1021/ja067367+. http://dx.doi.org/10.1021/ja067367+.
57. Carrotta R, Bauer R, Waninge R, Rischel C (2001) Conformational characterization of oligomeric intermediates and aggregates in beta-lactoglobulin heat aggregation. Protein Sci 10: 1312-1318.
58. Kuwahara H, Yamasaki T, Hatakeyama T, Aoyagi H, Fujisawa T (2002) Oligomerization process of the hemolytic lectin cel-iii purified from a sea cucumber, cucumaria echinata. J Biochem (Tokyo) 131: 751-756.
59. Calamai M, Chiti F, Dobson CM (2005) Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys J 89: 4201-4210. doi:10.1529/biophysj.105.068726. Available: http://dx.doi.org/10. 1529/biophysj.105.068726. Accessed 8 August 2007.
60. Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, et al. (2000) Amyloid fibril formation by a beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state nmr. Biochemistry 39: 13748-13759.
61. Favrin G, Irbäck A, Sjunnesson F (2001) Monte carlo update for chain molecules: Biased gaussian steps in torsional space. J Chem Phys 114: 8154-8158.
62. Shimada J, Kussell EL, Shakhnovich EI (2001) The folding thermodynamics and kinetics of crambin using an all-atom monte carlo simulation. J Mol Biol 308: 79-95. doi:10.1006/jmbi.2001.4586. Available: http://dx.doi.org/10.1006/ jmbi.2001.4586. Accessed 8 August 2007.
63. ten Wolde PR, Ruiz-Montero, Frenkel D (1995) Numerical evidence for bcc ordering at the surface of a critical fcc nucleus. Phys Rev Lett 75: 2714-2717.
64. Auer S, Frenkel D (2004) Quantitative prediction of crystal-nucleation rates for spherical colloids: A computational approach. Annu Rev Phys Chem 55: 333-361. doi:10.1146/annurev.physchem.55.091602.094402. Available: http://dx.doi.org/10.1146/annurev.physchem.55.091602.094402. Accessed 8 August 2007.